Mechanistically, mTOR inhibition not only restricts tumor growth but also enhances T cell activation to augment tumor specific immunity, underscoring the therapeutic potential of mTOR inhibitor in T cell lymphomas (9). Here, MTOR is linked to T-cell non-Hodgkin lymphoma.